Live Quote · OTCESALYHealthcare · Drug Manufacturers - Specialty & Generic

Eisai Co., Ltd.

$61.51▼ 2.11%($-1.32)

TickerSpark Score

76/100

▌ Solid

88

Valuation

65

Profitability

75

Growth

92

Health

60

Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ESALY research report →

52-Week Range67% of range

Low

$36.88

Current

$61.51

High

$73.90

Company Overviewwww.eisai.co.jp

About the company

Headquartered in Tokyo, Japan, Eisai Co. , Ltd. is a pharmaceutical company that develops and markets a diverse range of medicinal products within Japan.

CEO: Haruo Naito
IPO: 1995
Employees: 11,092
HQ: Tokyo, JP

Price Chart

+8.67% · this period

Valuation

Market Cap: $17.64B
P/E: 31.12
P/S: 1.45
P/B: 1.33
EV/EBITDA: 11.90
Div Yield: 3.76%

Profitability

Gross Margin: 76.83%
Op Margin: 4.87%
Net Margin: 4.67%
ROE: 4.44%
ROIC: 2.75%

Growth & Income

Revenue: $756.23B · 17.07%
Net Income: $45.72B · 8.54%
EPS: $159.44 · 8.51%
Op Income: $58.39B
FCF YoY: 115.98%

Performance & Tape

52W High: $73.90
52W Low: $36.88
50D MA: $66.46
200D MA: $51.33
Beta: 0.00
Avg Volume: 30.26K

Get TickerSpark's AI analysis on ESALY

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Coverage · ESALY